News and Congresses

Joint 3rd Donau Symposium and 4th AIT Austrian Biomarker Symposium

This meeting will highlight important aspects of image based and other noninvasive biomarker derivation and quantification. The 3rd Danube Symposium takes place in close succession of the 2014 and 2016 Danube Symposia and will be co-organized for the first time in conjunction with the AIT Austrian Institute of Technology. 

Highlights of the 2020 meeting include dedicated sessions on novel technologies in the context of liquid biopsy analysis, whole body dynamic molecular imaging as well as the establishment of novel biomarkers on organ crosstalk and systemic signaling. A clear focus in this year`s meeting will be the clinical evidence of diagnostic biomarkers in addition to novel approaches in systems medicine. The meeting is open to free papers, which will be presented as posters and rapid-fire talks. 

Our team is going to be present at dedicated BioVendor booth, so do not hesitate to visit us!

Frontiers in CardioVascular Biomedicine 2020

The Frontiers in CardioVascular Biomedicine meetings are increasingly considered as one of the most relevant exchange platforms for basic and translational cardiovascular biomedicine. Our Programme is designed to be cross-disciplinary, both between and within sessions, to emphasise underlying scientific developments important to cardiovascular biomedicine.

Key Figures:

• 700 participants
• Participants from 40+ countries
• Over 500 submitted abstracts
• 5 Keynote lectures
• 40+ sessions
• 100+ international faculty

Our team is going to be present at our dedicated BioVendor booth, so do not hesitate to visit us!

Precision Diagnostics Europe 2020

 We are excited to announce that we are taking part in Precision Diagnostics Europe 2020 (PDE2020). 

PDE2020 focuses on quality aspects of molecular analysis and diagnostics required for Precision Medicine and Personalised Therapies. Focus is on most recent molecular methods including liquid biopsies and single cell profiling discussing sensitivity, specificity and reproducibility aspects.

It is also our pleasure to invite you to a presentation by professor Kubista: Two-Tailed PCR for Precision Diagnostics.

We are looking forward to meeting you at PDE 2020!

EAS 2020

During the meeting we will explore the latest developments in research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment.

One of the features of EAS Congress is the high-level interdisciplinary exchange between clinicians and basic researchers. With many world-leading experts already confirmed, the EAS 2020 Geneva scientific programme will offer a bench-to-bedside overview of the latest current research in the field - including the award-winning Anitschkow Lecture, outstanding Keynote Lectures, state-of-the-art Plenary Sessions, and focused Workshops and Advance Clinical Seminars.

Our team is going to be present with our poster - The next step in the clinical use of microRNAs: the elimination of heparin interference, so do not hesitate to join us at EAS 2020!